Warning: The NCBI web site requires JavaScript to function. more...
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.
Dent AE, Chelimo K, Sumba PO, Spring MD, Crabb BS, Moormann AM, Tisch DJ, Kazura JW.
Malar J. 2009 Jul 16;8:162.
Related citations
Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.
King CL, Malhotra I, Wamachi A, Kioko J, Mungai P, Wahab SA, Koech D, Zimmerman P, Ouma J, Kazura JW.
J Immunol. 2002 Jan 1;168(1):356-64.
Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
John CC, O'Donnell RA, Sumba PO, Moormann AM, de Koning-Ward TF, King CL, Kazura JW, Crabb BS.
J Immunol. 2004 Jul 1;173(1):666-72.
Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
Dent A, Malhotra I, Mungai P, Muchiri E, Crabb BS, Kazura JW, King CL.
J Immunol. 2006 Nov 15;177(10):7139-45.
Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.
Spring MD, Chelimo K, Tisch DJ, Sumba PO, Rochford R, Long CA, Kazura JW, Moormann AM.
Infect Immun. 2010 Oct;78(10):4431-41. Epub 2010 Aug 9.
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.
Infect Immun. 2006 May;74(5):2887-93.
Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda.
Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG.
East Afr Med J. 2000 Apr;77(4):189-93.
Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons.
Omosun YO, Anumudu CI, Adoro S, Odaibo AB, Sodeinde O, Holder AA, Nwagwu M, Nwuba RI.
Acta Trop. 2005 Sep;95(3):233-47.
Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.
Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA.
Infect Immun. 1996 Jul;64(7):2716-23.
Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.
Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, Guindo AB, Kone AK, Traore K, Ouattara A, Djimde AA, Sehdev PS, Lyke KE, Diallo DA, Doumbo OK, Plowe CV.
PLoS Med. 2007 Mar;4(3):e93.
A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.
Dent AE, Yohn CT, Zimmerman PA, Vulule J, Kazura JW, Moormann AM.
Am J Trop Med Hyg. 2007 Aug;77(2):250-5.
Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India.
Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW, Woehlbier U, Bujard H, Dash AP, Singh N, Stiles JK, Udhayakumar V.
Malar J. 2008 Jul 4;7:121.
Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
Tonhosolo R, Wunderlich G, Ferreira MU.
J Eukaryot Microbiol. 2001 Sep-Oct;48(5):556-64.
Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.
Kabilan L, Sharma VP, Kaur P, Ghosh SK, Yadav RS, Chauhan VS.
Infect Immun. 1994 Feb;62(2):685-91.
The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.
Sutton PL, Clark EH, Silva C, Branch OH.
Malar J. 2010 Jan 4;9:3.
Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
Mamillapalli A, Sunil S, Diwan SS, Sharma SK, Tyagi PK, Adak T, Joshi H, Malhotra P.
Malar J. 2007 Jul 20;6:95.
Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
Dent AE, Bergmann-Leitner ES, Wilson DW, Tisch DJ, Kimmel R, Vulule J, Sumba PO, Beeson JG, Angov E, Moormann AM, Kazura JW.
PLoS One. 2008;3(10):e3557. Epub 2008 Oct 29.
Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.
McCallum FJ, Persson KE, Mugyenyi CK, Fowkes FJ, Simpson JA, Richards JS, Williams TN, Marsh K, Beeson JG.
PLoS One. 2008;3(10):e3571. Epub 2008 Oct 29.
The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens.
Mayengue PI, Luty AJ, Rogier C, Baragatti M, Kremsner PG, Ntoumi F.
Microbes Infect. 2009 Jan;11(1):108-14. Epub 2008 Nov 6.
Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
Torres KJ, Clark EH, Hernandez JN, Soto-Cornejo KE, Gamboa D, Branch OH.
Malar J. 2008 Sep 9;7:173.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on